CanSino Biologics Inc

6185.HK

$2.35

Closing

▲5.14%

1D

▼-21.87%

YTD

Market cap

$1.08B

52 week high

$5.26

52 week low

$1.89

Volume

2,333,400

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$1.08B

Analysts' Rating

BUY

Price Target (Mean)

0.00

Total Analysts

1

P/E

Operating Margin

0.00%

Beta

0.54

Revenue Growth (Annual)

-

52 week high

$5.26

52 week low

$1.89

Div. Yield

%

EPS Annual Growth

229.46

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company’s products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.